MIT Holding Inc. Announces Exclusive Distribution Agreement for Vivathermic Vials with Vivakor, Inc.

Published: Oct 21, 2010

SAVANNAH, Ga.--(BUSINESS WIRE)--MIT Holding, Inc. (OTCBB:MITD) announces today that it has entered into an exclusive licensing agreement with Vivakor, Inc. (OTCBB:VIVK) to manage the distribution of Vivakor’s patented Vivathermic Vials worldwide. MIT Holding, Inc.’s Co-Chairman and Co-President, Walter H.C. Drakeford issued the following statement, “MIT Holding, Inc. continues forward with its objective and mission of improving the quality of life. Vivathermic technology is a piece of that objective and adds to our portfolio of technologies as we continue to build shareholder value while improving life.” MIT’s Co-Chairman and Co-President, William Parker adds, “the agreement with Vivakor and the Vivathermic Vials will be a great compliment to MIT’s list of products, which will service the medical community including MIT’s family of companies.”

Back to news